Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
1-(5,6,7,8-Tetrahydronaphthalen-1-yl)piperazine → 7-{4-[4-(5,6,7,8-Tetrahydro-naphthalen-1-yl)-piperazin-1-yl]-butoxy}-5-trifluoromethyl-3,4-dihydro-1H-[1,8]naphthyridin-2-one
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 1-(5,6,7,8-Tetrahydronaphthalen-1-yl)piperazine | HCID 98698 | — |
| 반응물 | 4-(7-Oxo4-trifluoromethyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde | HCID 21073376 | — |
| 생성물 | 7-{4-[4-(5,6,7,8-Tetrahydro-naphthalen-1-yl)-piperazin-1-yl]-butoxy}-5-trifluoromethyl-3,4-dihydro-1H-[1,8]naphthyridin-2-one | HCID 21073705 | — |
반응 단계
In a manner similar to that of other examples above, 1-(5,6,7,8-tetrahydro-naphthalen-1-yl)-piperazine was coupled by reductive amination to 4-(7-oxo-4-trifluoromethyl-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde followed by typical workup and purification to give the title compound. MS: APCI: M+1: 503.1 (Exact Mass: 502.26).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07160888B2 |
| 출처 데이터셋 | uspto-grants-2007_01 |
| ORD ID | ord-7b3c6ee8403349ebbc719e70bc756807 |
| 출처 메모 | uspto-grants-2007_01 |